Table 3.

Primary Efficacy Assessment: Erosion Improvement Rates

	Fexuprazan		Placebo
	20 mg once a day	10 mg twice a day
Full-analysis set
No. of patients	102	102	96
Erosion improvement rate, No. (%)	59 (57.8)	67 (65.7)	39 (40.6)
Common risk difference (95% CI)	17.0 (3.3–30.6)	25.1 (11.7–38.6)
p-value*	0.017	<0.001
Per-protocol set
No. of patients	95	102	93
Erosion improvement rate, No. (%)	56 (58.9)	67 (65.7)	38 (40.9)
Common risk difference (95% CI)	17.9 (3.9–31.9)	24.9 (11.3–38.5)
p-value*	0.014	<0.001

CI, confidence interval.

*Compared with the placebo group.